Breaking
IEEE Spectrum IEEE Smart Village Is Helping to Electrify Rural Cameroon Space.com Should Saturn's huge moon Titan be humanity's next destination, after the moon and Mars? The Guardian Flaws in Kenya’s AI-driven health reforms driving up costs for the poorest Entrepreneur Magazine How to Build Loyalty in a Job-Hopping Economy TechCrunch India’s first space tech unicorn emerges as Skyroot gears up for orbital launch
Breaking
IEEE Spectrum IEEE Smart Village Is Helping to Electrify Rural Cameroon Space.com Should Saturn's huge moon Titan be humanity's next destination, after the moon and Mars? The Guardian Flaws in Kenya’s AI-driven health reforms driving up costs for the poorest Entrepreneur Magazine How to Build Loyalty in a Job-Hopping Economy TechCrunch India’s first space tech unicorn emerges as Skyroot gears up for orbital launch
Nature Medicine

Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial

Amy D. Klion 2026-05-05 · Health
myndfocal
Nature Medicine, Published online: 05 May 2026; doi:10.1038/s41591-026-04425-3 Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial

Nature Medicine, Published online: 05 May 2026;

doi:10.1038/s41591-026-04425-3

Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial

— Source: Nature Medicine (https://www.nature.com/articles/s41591-026-04425-3)

Health
Read original on Nature Medicine →